Takara PrimePath SARS-CoV-2 VLP-RNA Control

PrimePath SARS-CoV-2 VLP-RNA Control offers a simple and effective way to reduce false negatives for RT-qPCR-based SARS-CoV-2 detection assays. The encapsulated RNA design allows you to monitor the success of every step in your SARS-CoV-2 detection workflow with just one product, from initial extraction to amplification, and helps ensure accuracy in your molecular diagnostic testing.

PrimePath SARS-CoV-2 VLP-RNA Control offers a simple and effective way to reduce false negatives for RT-qPCR-based SARS-CoV-2 detection assays. The encapsulated RNA design allows you to monitor the success of every step in your SARS-CoV-2 detection workflow with just one product, from initial extraction to amplification, and helps ensure accuracy in your molecular diagnostic testing.

Composed of a highly stable, nuclease-resistance RNA consisting of a portion of the SARS-CoV-2 N gene encapsulated in virus-like particle (VLP) shells, PrimePath SARS-CoV-2 VLP-RNA Control better mimics typical SARS-CoV-2 test samples than DNA- or naked RNA-based controls.

More Less